These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8880053)

  • 1. Population pharmacokinetics and pharmacodynamics of oral levodopa in parkinsonian patients.
    Triggs EJ; Charles BG; Contin M; Martinelli P; Cortelli P; Riva R; Albani F; Baruzzi A
    Eur J Clin Pharmacol; 1996; 51(1):59-67. PubMed ID: 8880053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients.
    Simon N; Viallet F; Boulamery A; Eusebio A; Gayraud D; Azulay JP
    Eur J Clin Pharmacol; 2016 Apr; 72(4):423-30. PubMed ID: 26936272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
    Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
    Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease.
    Harder S; Baas H
    Clin Pharmacol Ther; 1998 Aug; 64(2):183-91. PubMed ID: 9728899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuations.
    Baas H; Harder S; Bürklin F; Demisch L; Fischer PA
    Clin Neuropharmacol; 1998; 21(2):86-92. PubMed ID: 9579293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacodynamic modeling of levodopa in patients with Parkinson's disease receiving entacapone.
    Trocóniz IF; Naukkarinen TH; Ruottinen HM; Rinne UK; Gordin A; Karlsson MO
    Clin Pharmacol Ther; 1998 Jul; 64(1):106-16. PubMed ID: 9695725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.
    Contin M; Martinelli P; Mochi M; Riva R; Albani F; Baruzzi A
    Mov Disord; 2005 Jun; 20(6):734-9. PubMed ID: 15747357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson's disease.
    Chan PL; Nutt JG; Holford NH
    J Pharmacokinet Pharmacodyn; 2005 Aug; 32(3-4):459-84. PubMed ID: 16320101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion.
    Westin J; Nyholm D; Pålhagen S; Willows T; Groth T; Dougherty M; Karlsson MO
    Clin Neuropharmacol; 2011; 34(2):61-5. PubMed ID: 21297456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson's disease patients.
    Senek M; Nyholm D; Nielsen EI
    Eur J Clin Pharmacol; 2018 Oct; 74(10):1299-1307. PubMed ID: 29882153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[18F]levodopa positron emission tomography in patients with Parkinson's disease.
    Dietz M; Harder S; Graff J; Künig G; Vontobel P; Leenders KL; Baas H
    Clin Pharmacol Ther; 2001 Jul; 70(1):33-41. PubMed ID: 11452242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic modeling of concentration-effect relationships after controlled-release carbidopa/levodopa (Sinemet CR4) in Parkinson's disease.
    Nelson MV; Berchou RC; LeWitt PA; Kareti D; Galloway MP
    Neurology; 1990 Jan; 40(1):70-4. PubMed ID: 2296385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic modeling of L-dopa plasma concentrations and clinical effects in Parkinson's disease after Sinemet.
    Nelson MV; Berchou RC; Lewitt PA; Kareti D; Kesaree N; Schlick P; Galloway MP
    Clin Neuropharmacol; 1989 Apr; 12(2):91-7. PubMed ID: 2720699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson"s disease patients experiencing motor fluctuations with levodopa.
    Okereke CS
    J Pharm Pharm Sci; 2002; 5(2):146-61. PubMed ID: 12207867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the short- and long-duration responses to exogenous levodopa and to endogenous levodopa production in Parkinson's disease.
    Chan PL; Nutt JG; Holford NH
    J Pharmacokinet Pharmacodyn; 2004 Jun; 31(3):243-68. PubMed ID: 15518246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic relationship of levodopa with and without tolcapone in patients with Parkinson's disease.
    Baas H; Zehrden F; Selzer R; Kohnen R; Loetsch J; Harder S
    Clin Pharmacokinet; 2001; 40(5):383-93. PubMed ID: 11432539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease.
    Deleu D; Jacob P; Chand P; Sarre S; Colwell A
    Neurology; 2006 Sep; 67(5):897-9. PubMed ID: 16966563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic modeling of oral levodopa: clinical application in Parkinson's disease.
    Contin M; Riva R; Martinelli P; Cortelli P; Albani F; Baruzzi A
    Neurology; 1993 Feb; 43(2):367-71. PubMed ID: 8437704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa therapy monitoring in patients with Parkinson disease: a kinetic-dynamic approach.
    Contin M; Riva R; Martinelli P; Albani F; Avoni P; Baruzzi A
    Ther Drug Monit; 2001 Dec; 23(6):621-9. PubMed ID: 11802094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.
    Neef C; van Laar T
    Clin Pharmacokinet; 1999 Sep; 37(3):257-71. PubMed ID: 10511920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.